Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01238432 · ClinicalTrials.gov registry record
The Genetics of Severe Asthma in Children
A clinical trial, sponsored by Connecticut Children's Medical Center.
- Completed
- Registry status
- 193
- Enrollment target
NCT01238432: Completed study, sponsored by Connecticut Children's Medical Center.
NCT01238432 is a clinical trial that has completed, run by Connecticut Children's Medical Center. The registered enrollment target is 193 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01238432 has completed, sponsored by Connecticut Children's Medical Center.
- COMPLETED
- Registry status
- 193 participants
- Enrollment target
Study Summary
Near fatal asthma exacerbations are one of the most common causes of critical illness in children, accounting for approximately ten thousand intensive care unit (ICU) admissions per year in the United States. Even children with intermittent or mild baseline asthma can develop these severe exacerbations; however, there are few studies evaluating the risk factors associated with the development of near fatal asthma exacerbations in children. Inhaled β2-adrenergic receptor (ADRβ2) agonist therapy is the foundation of therapy for acute asthma and genetic variations of this receptor have been shown to affect response to ADRβ2 agonist therapy in this population. The investigators hypothesis is that a child's ADRβ2 genotype is associated with the development of a near fatal asthma exacerbation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 193 participants |
| Start Date | 2009-10 |
| Est. Completion | 2018-04 |
What the finished NCT01238432 record still lists
NCT01238432 is an observational study that tracks outcomes without assigning an intervention. The registered 193 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01238432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01238432 about?
NCT01238432 is a clinical study titled "The Genetics of Severe Asthma in Children". Near fatal asthma exacerbations are one of the most common causes of critical illness in children, accounting for approximately ten thousand intensive care unit (ICU) admissions per year in the United States. Even children with intermittent or mild baseline asthma can develop these severe exacerbati...
What is the current status of trial NCT01238432?
This trial is currently completed. The enrollment target is 193 participants. The study started on 2009-10. Estimated completion is 2018-04.
Who is sponsoring clinical trial NCT01238432?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06226220 · 193 participants · NA
Percutaneous Nerve Evaluation Trial Time
- NCT03593759 · 194 participants · Phase 3
Cardiac Sarcoidosis Randomized Trial
- NCT05053152 · 194 participants · Phase 2
Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study
- NCT05156112 · 194 participants · NA
OSA PAP Treatment for Veterans With SUD and PTSD on Residential Treatment Unit
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia